Skip to content

Dr. Tom Robben

Active Private limited companyfounded 2023active for 3 yearsTrootstraat 29, 3721 HasseltKBO/BCE: BE 1002.109.968

Lifetime

2 annual accounts with figures on one time axis
peak of €124,389 in 2025
€124,389▲ 2.7%
peak of €87,076 in 2025
€87,076▲ 1.2%
peak of €175,144 in 2025
€175,144▲ 103%
€13,708▼ 46.2%
Board1 name since 2023
1 director
Documentsfilings and deeds
10-07-202621 days before the deadline
2025micro format
Equity from €86,068 to €175,144Debts from €25,458 to €13,708Investments €26,973Cash from €90,615 to €5,589

Key points

from the 2025 annual accounts

Equity

€175,144 ▲ 103%
€86,1002024€175,0002025

Equity rose in 2025 from €86,068 to €175,144.

Turnover

≈ €220,000 estimated

The micro format states no turnover.

Investments

€27,039 5.2 times depreciation
20242025

Green is investment, beige is depreciation.

Liquidity

12.09 was 4.33 in 2024

Short-term debts fell from €25,458 to €13,708.

Position in the sector

92.7%

Higher solvency than 87% of companies in human health. The sector median is 63.1%, over 21,368 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as Dr. Tom Robben has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for Dr. Tom Robben. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 09-11-2023
  • 100 sharesdeed of 13-11-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1002109968
Incorporation Founding capital of €2,000, 100 shares · Founded by · appointed as director · published on 13-11-2023 · Gazette deed
First establishment Trootstraat 29, Hasselt
All 7 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Tom Robben Hasselt €188,852 €124,389 92.7% -
Dr. Laura Van Baelen Bocholt €185,968 €115,491 98.8% -
Etienne Gombert Kasterlee €186,787 €125,239 94.0% -
Médical DDK Verviers €190,302 €123,616 96.3% -
Dr. Oris Toon Merchtem €190,708 €127,342 98.9% -
DR CHLOE LAHAISE Tournai €196,244 €130,751 95.5% -
Dr. Kobe Willems Antwerp €195,800 €118,424 73.3% -

These companies have the same main activity as Dr. Tom Robben: general medical practice (NACE 86210). They are comparable in size and age: total assets between €186,000 and €196,000, founded in 2023.

Official details

Source: KBO
Status
Active since 09-11-2023Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.351.822.0123721 Hasselt, since 09-11-2023
Financial year end
31 December
Peppol
Reachable since 05-01-2026
Company details

Annual accounts 2025

€188,852▲ 69.3%
Filing
Filed on 10-07-2026, 21 days before the end of the filing period
Financials

Insights on Dr. Tom Robben

Dr. Tom Robben has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €175,144 and a net result of €87,076.

Its solvency ranks better than 88% of 21,368 sector peers (NACE 86) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Tom Robben

What is the company number of Dr. Tom Robben?
The company number of Dr. Tom Robben is 1002.109.968. The VAT number is the same number with BE in front: BE 1002.109.968.
Where is Dr. Tom Robben based?
The registered office is at Trootstraat 29, 3721 Hasselt.Company details
What does Dr. Tom Robben do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Tom Robben?
Dr. Tom Robben is a private limited company (BV).
When was Dr. Tom Robben founded?
Dr. Tom Robben was founded on 09-11-2023.
Is Dr. Tom Robben still active?
Yes, Dr. Tom Robben is an active enterprise in the KBO register.
What is the turnover of Dr. Tom Robben?
The turnover in financial year 2025 is about €220,000. This figure is estimated from the gross margin of €124,389 and 30 comparable companies (NACE 86210). It probably lies between €180,000 and €280,000.Financials
Is Dr. Tom Robben profitable?
In financial year 2025, Dr. Tom Robben made a profit of €87,076.
Where can I find the annual accounts of Dr. Tom Robben?
Dr. Tom Robben filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Tom Robben due?
Dr. Tom Robben must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.